NEOG · Neogen Corporation
$9.61
-2.24% last session
End-of-day data · updated 2026-07-25
Market cap
$2B
Enterprise value
$3B
Trailing P/E
—
Forward P/E
31.3
Dividend yield
—
Beta
1.79
Avg volume
2M
Employees
3K
2D change
-2.19%
5D change
-6.09%
10D change
-5.81%
30D change
-1.16%
60D change
2.84%
MTD change
0.97%
YTD change
34.48%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — NEOG
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-01-12
Latest call per bank · past 12 months
Recent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-01-12 | Piper Sandler | Reiterates | Neutral | $6.50 → $10.00 |
| 2026-01-09 | Guggenheim | Maintains | Buy | $8.00 → $12.00 |
| 2025-12-10 | CJS Securities | Upgrade | Market Perform → Market Outperform | $0.00 → $10.00 |
| 2025-10-16 | Piper Sandler | Reiterates | Neutral | $5.00 → $6.50 |
| 2025-09-29 | CJS Securities | Initiates | Market Perform | $0.00 → $10.00 |
| 2025-07-29 | William Blair | Downgrade | Outperform → Market Perform | $0.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-23
- RSI (14): RSI is 51 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 4.2% above the 50-day MA ($9.22).
- Price vs 200-day MA: Trading 12.4% above the 200-day MA ($8.55).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.00) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($4.65) and high ($11.33).
NEOG Price Chart
Loading chart for NEOG…
Fundamentals
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
More in Medical Devices
ABT
Abbott Laboratories
$180B -16.2% YTD
SYK
Stryker Corporation
$127B -5.5% YTD
MDT
Medtronic plc.
$107B -11.9% YTD
BSX
Boston Scientific Corporation
$66B -53.6% YTD
EW
Edwards Lifesciences Corporatio
$48B -3.1% YTD
GEHC
GE HealthCare Technologies Inc.
$28B -26.1% YTD
DXCM
DexCom, Inc.
$28B 7.8% YTD
PHG
Koninklijke Philips N.V. NY Reg
$25B 0.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.